Selected article for: "fatal outcome and immune system"

Author: Schwartz, Robert A.; Pradhan, Swetalina; Murrell, Dedee F.; Jafferany, Mohammad; Olisova, Olga Yu.; Lomonosov, Konstantin M.; Lotti, Torello; Goldust, Mohamad
Title: COVID‐19 and Immunosuppressive therapy in Dermatology
  • Cord-id: dwwwvlpx
  • Document date: 2020_8_7
  • ID: dwwwvlpx
    Snippet: Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an indivduals's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID‐19 but requiring a systemic immunosuppressant, keeping in view the challenge of the C
    Document: Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an indivduals's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID‐19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID‐19 infection. This article is protected by copyright. All rights reserved.

    Search related documents:
    Co phrase search for related documents